Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE).
Purity:
95.00%
CAS Number:
[2229685-51-0]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted